Lewy body variant of Alzheimer's disease:: α-synuclein in dystrophic neurites of Aβ plaques

被引：43
作者：
Wirths, O
Weickert, S
Majtenyi, K
Havas, L
Kahle, PJ
Okochi, M
Haass, C
Multhaup, G
Beyreuther, K
Bayer, TA
机构：
[1] Univ Bonn, Med Ctr, Dept Psychiat, D-53105 Bonn, Germany
[2] Inst Nervous & Mental Dis, Neuropathol Lab, H-111281 Budapest, Hungary
[3] Univ Munich, Dept Biochem, D-80336 Munich, Germany
[4] ZMBH, D-69120 Heidelberg, Germany
来源：
NEUROREPORT | 2000年 / 11卷 / 17期
关键词：
Alzheimer's disease; amyloid deposits; familial Alzheimer's disease; immunostaining; Lewy body; NAC; neuritic plaques; sporadic Alzheimer's disease; alpha-synuclein;
D O I：
10.1097/00001756-200011270-00029
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The contribution of alpha -synuclein accumulation in Alzheimer's disease (AD) plaques is currently a matter of scientific debate. In the present study antisera against the N- and C-terminus, the full-length protein and the central so-called non-amyloid component (NAC) domain of the alpha -synuclein protein were used to address this question in brains of cases with typical AD and of cases with the Lewy body (LB) variant of AD. In typical AD cases, none of the antisera revealed evidence for co-accumulation of alpha -synuclein with extracellular A beta peptides in plaques or in dystrophic neurites decorating the plaque core. Interestingly, cases with mixed pathology of the LB variant of AD revealed accumulation of alpha -synuclein in LBs and in dystrophic neurites of A beta plaques. NeuroReport 11:3737-3741 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码：3737 / 3741
页数：5
相关论文
共 50 条
[21]   14-3-3 protein sigma isoform co-localizes with phosphorylated αD-synuclein in Lewy bodies and Lewy neurites in patients with Lewy body disease [J].
Wakabayashi, Kaori ;
Umahara, Takahiko ;
Hirokawa, Katsuiku ;
Hanyu, Haruo ;
Uchihara, Toshiki .
NEUROSCIENCE LETTERS, 2018, 674 :171-175
[22]   2 TYPES OF DYSTROPHIC NEURITES IN SENILE PLAQUES OF ALZHEIMER-DISEASE AND ELDERLY NONDEMENTED CASES [J].
YASUHARA, O ;
KAWAMATA, T ;
AIMI, Y ;
MCGEER, EG ;
MCGEER, PL .
NEUROSCIENCE LETTERS, 1994, 171 (1-2) :73-76
[23]   Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease [J].
Ho, GJ ;
Hansen, LA ;
Alford, MF ;
Foster, K ;
Salmon, DR ;
Galasko, D ;
Thal, LJ ;
Masliah, E .
NEUROREPORT, 2002, 13 (14) :1825-1828
[24]   The Lewy body variant of Alzheimer’s disease: clinical, pathophysiological and conceptual issues [J].
H. Förstl .
European Archives of Psychiatry and Clinical Neuroscience, 1999, 249 (Suppl 3) :S64-S67
[25]   The Lewy body variant of Alzheimer's disease:: clinical, pathophysiological and conceptual issues [J].
Förstl, H .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 :64-67
[26]   Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique [J].
Sandmann-Keil, D ;
Braak, H ;
Okochi, M ;
Haass, C ;
Braak, E .
ACTA NEUROPATHOLOGICA, 1999, 98 (05) :461-464
[27]   Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease [J].
Dickson, TC ;
King, CE ;
McCormack, GH ;
Vickers, JC .
EXPERIMENTAL NEUROLOGY, 1999, 156 (01) :100-110
[28]   Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant [J].
Takehashi, M ;
Tanaka, S ;
Masliah, E ;
Ueda, K .
NEUROSCIENCE LETTERS, 2002, 327 (02) :79-82
[29]   Mutation in the α-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with Lewy bodies [J].
Higuchi, S ;
Arai, H ;
Matsushita, S ;
Matsui, T ;
Kimpara, T ;
Takeda, A ;
Shirakura, K .
EXPERIMENTAL NEUROLOGY, 1998, 153 (01) :164-166
[30]   Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease [J].
Gilbert, PE ;
Barr, PJ ;
Murphy, C .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2004, 10 (06) :835-842
12345